Chase Investment Counsel Corp Makes New Investment in BWX Technologies, Inc. $BWXT

Key Points

• Chase Investment Counsel purchased 6,029 shares of BWX Technologies during the second quarter, valued at approximately $1.17 million. Institutional investors collectively own 94.39% of the company.
• BWXT reported quarterly earnings of $1.07 per share, exceeding estimates of $1.04, while revenue rose 18% year over year to $901.62 million. The company reaffirmed fiscal 2026 EPS guidance of $4.70–$4.80.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and a $227.20 price target versus the stock’s reported $173.14 price. BWXT also declared a quarterly dividend of $0.27 per share, yielding 0.6% annually.

Chase Investment Counsel Corp purchased a new stake in BWX Technologies, Inc. (NYSE:BWXT - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 6,029 shares of the technology company's stock, valued at approximately $1,173,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. WFA of San Diego LLC purchased a new stake in shares of BWX Technologies during the second quarter worth approximately $29,000. MV Capital Management Inc. purchased a new position in BWX Technologies in the fourth quarter worth approximately $32,000. Tucker Asset Management LLC acquired a new position in BWX Technologies during the 4th quarter worth approximately $36,000. Vermillion Wealth Management Inc. grew its holdings in BWX Technologies by 71.7% during the 4th quarter. Vermillion Wealth Management Inc. now owns 237 shares of the technology company's stock worth $41,000 after acquiring an additional 99 shares in the last quarter. Finally, Smithfield Trust Co increased its position in shares of BWX Technologies by 52.1% in the 4th quarter. Smithfield Trust Co now owns 251 shares of the technology company's stock valued at $44,000 after purchasing an additional 86 shares during the last quarter. Hedge funds and other institutional investors own 94.39% of the company's stock.

BWX Technologies Trading Down 0.0%

NYSE:BWXT opened at $173.14 on Monday. The company has a market capitalization of $15.86 billion, a PE ratio of 44.86, a P/E/G ratio of 2.71 and a beta of 0.76. BWX Technologies, Inc. has a 52-week low of $157.10 and a 52-week high of $241.82. The stock's 50 day moving average price is $183.41 and its 200 day moving average price is $199.02. The company has a quick ratio of 2.33, a current ratio of 2.40 and a debt-to-equity ratio of 1.51.

BWX Technologies (NYSE:BWXT - Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The technology company reported $1.07 earnings per share for the quarter, beating analysts' consensus estimates of $1.04 by $0.03. The company had revenue of $901.62 million during the quarter, compared to analysts' expectations of $902.41 million. BWX Technologies had a return on equity of 30.83% and a net margin of 10.11%.The firm's revenue for the quarter was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.02 earnings per share. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. On average, research analysts anticipate that BWX Technologies, Inc. will post 4.75 EPS for the current year.

BWX Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Tuesday, August 18th will be given a $0.27 dividend. The ex-dividend date is Tuesday, August 18th. This represents a $1.08 annualized dividend and a yield of 0.6%. BWX Technologies's dividend payout ratio is 27.98%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on BWXT shares. BTIG Research restated a "buy" rating and issued a $235.00 price objective on shares of BWX Technologies in a report on Tuesday, August 4th. Zacks Research downgraded shares of BWX Technologies from a "strong-buy" rating to a "hold" rating in a research note on Monday, May 11th. Deutsche Bank Aktiengesellschaft upgraded shares of BWX Technologies from a "hold" rating to a "buy" rating and boosted their target price for the stock from $205.00 to $255.00 in a research note on Friday, May 15th. Seaport Research Partners upgraded BWX Technologies from a "neutral" rating to a "buy" rating and set a $245.00 price target on the stock in a research note on Monday, June 22nd. Finally, Wall Street Zen cut BWX Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $227.20.

Insider Buying and Selling

In related news, CEO Rex D. Geveden sold 10,000 shares of the company's stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $172.50, for a total value of $1,725,000.00. Following the completion of the sale, the chief executive officer owned 192,491 shares in the company, valued at $33,204,697.50. This represents a 4.94% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

BWX Technologies Profile

BWX Technologies, Inc NYSE: BWXT is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company's core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source